The japanese pharmaceutical industry the new drug lag and the failure of industrial policy

Almost 90 per cent of new drugs are unavailable in Japan. This book presents an analysis of the nature, causes and consequences of this problem, contrasting the Japanese situation with the drug lag experienced in the US. The last chapters look at the various remedies available.